Summer of 2023 Was Hottest in 2,000 Years

High temperatures across the Northern Hemisphere last summer were scorching and frequent enough to make it the hottest summer in two millennia, new research shows.

Weather records based on scientific instruments only goes back as far as 1850, noted researchers at Cambridge University in England. That data already had confirmed the summer o...

San Francisco Set to Ban 'Forever Chemicals' in Firefighter Gear

San Francisco is on the verge of passing a ban on "forever chemicals" in the protective clothing firefighters wear while battling blazes.

City lawmakers are expected to pass an ordinance on Tuesday that will prohibit the use of firefighting gear made with per- and polyfluoroalkyl substances (PFAS).

PFAS have been linked to heal...

More Studies Support Wegovy's Long-Term Weight-Loss Benefits

Semaglutide -- the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy -- can produce long-term weight and heart health benefits, a pair of new studies show.

Researchers found that overweight and obese adults lost an average 10% of their body weight and nearly three inches off their waistline after taking semaglutide ...

Americans With Private Insurance May Pay More for Hospital Stay

Having private insurance may not be all it is cracked up to be when it comes to hospital bills, new research warns.

In a report published Monday by the nonprofit research institute RAND Corp., researchers discovered that patients with private health insurance may wind up paying more for procedures or tests performed during their ...

Patients Over 80 Still Benefit From Treatment for AML Blood Cancer

Seniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted therapy for the blood cancer, a new study finds.

The oral drug venetoclax is typically given to older AML patients whose bodies can’t handle the rigors of chemotherapy. The drug targets a protein in cancer cells that helps them live longer t...

Why C-Section Babies Need 2 Doses of Measles Vaccine

Babies born by C-section are unlikely to receive protection from a single dose of measles vaccine, a new study finds.

A single measles jab is up to 2.6 times more likely to be completely ineffective in C-section babies, compared to those born vaginally. Their immune systems fail to produce antibodies to fight against measles infection.